PS
Insider selling
Peter Scott Chin sold $37K of Denali Therapeutics Inc. (DNLI) stock
Peter Scott Chin, Chief Medical Officer of Denali Therapeutics Inc. (DNLI), sold 1,654 shares of DNLI stock worth $37K, per an SEC Form 4 filed Sep 9, 2026.
It was an open-market sale.
The trade happened on Sep 4, 2026, 5 days before it was made public.
DNLI has moved -3.1% since the trade date, from $22.28 to $21.60 (Sep 22, 2026 close).
- Traded
- Sep 4, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 5 days
- Price since
- -3.1%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More DNLI insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.